Acuity (AYI) has just posted its latest figures for Q2 2026, with quarterly revenue of US$1.14b and basic EPS of US$3.92 setting the tone for the release as investors weigh how much earnings power the business is currently putting through the income statement. Over recent quarters the company has seen revenue move from US$1.01b in Q2 2025 to US$1.18b in Q3 2025, US$1.21b in Q4 2025 and then US$1.14b in Q1 2026. Basic EPS over the same stretch went from US$2.50 to US$3.19, US$3.71 and US$3.92, so the focus now is firmly on how much of that top line is sticking as profit. With trailing net margin at 9% and below the prior year’s 11.1%, this set of results puts profitability efficiency at the center of the discussion.
See our full analysis for Acuity.With the latest numbers on the table, the next step is to see how this earnings profile lines up with the most widely shared narratives about Acuity and where those stories might need updating.
See what the community is saying about Acuity
Margins Slip From 11.1% To 9%
- Over the last 12 months, Acuity generated US$4.54b in revenue and US$410.4 million in net income, which works out to a 9% net margin compared with 11.1% a year earlier.
- Consensus narrative expects margin improvement over time, yet the current 9% margin sits below that earlier 11.1% level. This creates a gap between story and reality.
- Analysts see profit margins eventually rising toward 11.8%, but the trailing margin is still closer to 9% on US$4.54b of revenue.
- That means any thesis that depends on richer margins needs to be squared with the recent compression from 11.1% to 9%.
TTM EPS Of US$13.32 With Mixed Growth Signals
- On a trailing basis, EPS sits at US$13.32 and net income at US$410.4 million, compared with US$422.6 million a year earlier, even though five year earnings growth averaged 7.2% per year and the most recent year showed negative earnings growth.
- Analysts' consensus view highlights long run earnings growth, but the combination of a 7.2% five year EPS growth rate and a single year of negative earnings growth gives you a mixed picture to weigh.
- Revenue over the last year grew 5.6% per year, slower than the US market growth rate of 10.4% per year that the consensus often uses as a comparison point.
- So while the longer term EPS trend has been positive on average, the recent year of weaker earnings means you are not seeing a straight line when you look across the last few reporting periods.
P/E Of 19.7x And Reference Upside To US$383.38
- At a share price of US$265.39, Acuity trades on a 19.7x trailing P/E, compared with a peer average of 48.7x and an industry average of 33.1x, and against a DCF fair value of about US$403.90.
- Bulls point to the gap between today’s US$265.39 price and the US$383.38 analyst target as a possible upside window. The lower 19.7x P/E versus peers suggests the optimistic case rests partly on that valuation gap staying in place.
- Analysts also expect earnings to grow about 9.66% per year, which is below the 15.5% forecast for the broader US market, so the bullish view leans more on price versus value than on faster growth.
- With the stock trading roughly 34.3% below the DCF fair value of US$403.90, anyone focused on the bullish story will likely pay close attention to how quickly earnings and margins line up with those expectations.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Acuity on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
With sentiment in this review leaning toward cautious optimism, it is worth checking the underlying data yourself and testing how it fits your own thesis. If you want a quick way to see what is going right, start with the 4 key rewards.
See What Else Is Out There
Margins have slipped from 11.1% to 9%, recent earnings growth has been uneven, and the current 19.7x P/E relies heavily on the bullish narrative holding.
If that mix of margin pressure and valuation reliance makes you cautious, now is a good time to compare it with companies screened as having 67 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com